ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 194 filers reported holding ARRAY BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $5,556,000 | +100.0% | 119,925 | +5.2% | 0.00% | +50.0% |
Q1 2019 | $2,778,000 | +116.7% | 113,943 | +26.6% | 0.00% | +100.0% |
Q4 2018 | $1,282,000 | +11.6% | 89,972 | +19.0% | 0.00% | 0.0% |
Q3 2018 | $1,149,000 | -10.4% | 75,632 | -1.0% | 0.00% | 0.0% |
Q2 2018 | $1,282,000 | -2.7% | 76,399 | -5.3% | 0.00% | 0.0% |
Q1 2018 | $1,317,000 | -1.1% | 80,685 | -22.3% | 0.00% | 0.0% |
Q4 2017 | $1,331,000 | +32.8% | 103,783 | +27.2% | 0.00% | 0.0% |
Q3 2017 | $1,002,000 | +77.0% | 81,578 | +20.6% | 0.00% | – |
Q2 2017 | $566,000 | +13.2% | 67,656 | +20.6% | 0.00% | – |
Q1 2017 | $500,000 | +39.7% | 56,110 | +37.3% | 0.00% | – |
Q4 2016 | $358,000 | +145.2% | 40,854 | +76.0% | 0.00% | – |
Q3 2016 | $146,000 | +78.0% | 23,211 | 0.0% | 0.00% | – |
Q2 2016 | $82,000 | +17.1% | 23,211 | 0.0% | 0.00% | – |
Q1 2016 | $70,000 | -34.0% | 23,211 | -9.5% | 0.00% | – |
Q4 2015 | $106,000 | -11.7% | 25,657 | 0.0% | 0.00% | – |
Q3 2015 | $120,000 | -35.1% | 25,657 | 0.0% | 0.00% | – |
Q2 2015 | $185,000 | -3.6% | 25,657 | 0.0% | 0.00% | – |
Q1 2015 | $192,000 | +56.1% | 25,657 | 0.0% | 0.00% | – |
Q4 2014 | $123,000 | +28.1% | 25,657 | 0.0% | 0.00% | – |
Q3 2014 | $96,000 | – | 25,657 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |